NVI Launches National Survey to Boost Ghana's Self-Sufficient Vaccine

In a landmark move toward pharmaceutical sovereignty, Ghana has officially launched a nationwide Vaccine Perception Survey designed to pave the way for locally manufactured vaccines.

The initiative, spearheaded by the National Vaccine Institute (NVI), arrives as the country prepares for a critical transition away from the support of the Global Alliance for Vaccines and Immunization (GAVI) by 2030.

This shift represents a defining moment in Ghana’s journey toward health security and the independent funding of its own medical supplies.

The survey serves as a strategic foundation for ensuring that “Made-in-Ghana” vaccines are not only produced to rigorous safety standards but are also met with public trust.

Running from February 16 to March 10, 2026, the research spans 55 districts across all 16 regions.

The NVI aims to capture a comprehensive snapshot of the national landscape by engaging 11,077 respondents through structured interviews and qualitative focus group discussions.

In a press statement signed by Dr. Sodzi Sodzi-Tettey, Chief Executive Officer the project is rooted in transparency rather than promotion.

He noted that the institute genuinely seeks to listen to and understand the concerns of the populace to ensure that local manufacturing efforts are socially embraced.

By identifying the specific drivers of vaccine confidence and the barriers to acceptance, the NVI can develop evidence-based interventions tailored to the diverse realities of both urban and rural communities.

The scope of the study is particularly vital because vaccine hesitancy is not uniform across the country.

While some regions in Northern Ghana report higher levels of skepticism, urban centers often grapple with different patterns of misinformation.

The selection of the 55 participating districts was based on a strict criteria of geographic diversity and strategic relevance, ensuring the findings are generalizable to the broader population.

Approximately 200 respondents per district will provide the statistical power necessary to compare regional attitudes and identify the most trusted messengers for health communication.

Ultimately, the data gathered will establish a national baseline for vaccine confidence and examine how the approval of the Food and Drugs Authority (FDA) influences public perception.

This research directly supports the NVI’s core mandate to coordinate vaccine development while bridging the gap between technical manufacturing and public readiness.

As Ghana continues its legacy as a leader in West African immunization, this survey ensures that the future of its health self-sufficiency is built on a foundation of community engagement and mutual trust.

The National Vaccine Institute has therefore appealed to residents within the selected districts to participate actively, noting that their feedback will directly shape the government’s communication strategies.

Officials have reassured the public that participation is entirely voluntary and that all information collected will be handled with the strictest confidentiality to protect the voices of those contributing to Ghana’s healthy future.

Source: expressnewsghana.com